Examining Hepatitis C Virus Treatment Access
A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Last Updated on May 13, 2020 by HepFree NYC
Related Articles
-
Job | INHSU Fellow
INHSU Fellowship Program: Building Capacity to Support Women Who Use Drugs Apply Now The INHSU Fellowship Program is a nine-month mentorship and skills-development initiative for early and mid-career U.S. researchers and practitioners working to improve health outcomes for women ...
-
2019 Hep Free NYC Awareness Event on the Steps of City Hall
May Hepatitis Awareness Month, National Hepatitis Testing Day and Hispanic Hepatitis Awareness Day.
-
Obama Letter Urging Lift of State Medicaid Restrictions on Hep C Meds
The Obama Administration has released a letter, through the Centers for Medicare and Medicaid Services (CMS), calling on states to stop imposing conditions for coverage of HCV drugs that may unreasonably restrict access to these drugs.
-
National African American Hepatitis C Action Day – Hep C University
SAVE THE DATE! Wednesday, July 25th is the 6th Annual National African American Hepatitis C Action Day (NAAHCAD). This day provides an opportunity to promote Hepatitis C prevention, testing, and treatment messages to public health partners and the black community. NAAHCAD also pr...
-
Hepatitis A, B and C in New York City: 2023 Annual Report
The Hepatitis A, B and C in NYC: 2023 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
-
Survey | Adults on HCV meds in last year: $65
Fieldwork East Inc. is an independent national multi-office market research facility, specializing in medical research for new product development. Doctors, Nurses, Hospital Administrators and other professional individuals involved in a multitude of medical areas are invited to ...
-
Updated News | NYS Hep C Learning Collaborative Launched!
This web-based, public-facing, interactive dashboard system will present targets and key outcomes of the initiative to eliminate Hep C in NYS and serve as a comprehensive source of local and statewide Hep C-related data.
-
NYC DOHMH’s Request to Upgrade USPSTF’s Baby Boomer HCV Testing Rating
The USPSTF's draft recommendations on testing hepatitis C among injection drug users and others at high risk is a major improvement over previous guidelines (a grade “B”, meaning testing is recommended).
